drugset / Trial / NCT04597268
Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to assess the safety and efficacy of dexmedetomidine versus ketamine versus midazolam combined with propofol in cancer patients undergoing gastrointestinal endoscopic procedures.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2022-12-15
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intravenous |
| Subject | Ketamine | Small molecule | 1 mg/kg | Intravenous |
| Comparator | Midazolam | Small molecule | 0.05 mg/kg | Intravenous |
Indications
No indication recorded.